Residency · Cleveland, OH
Sponsored by Cleveland Clinic Foundation
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
The New England journal of medicine · 2022 · 755 citations · Suma Babu
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.
Journal of neurology, neurosurgery, and psychiatry · 2021 · 420 citations · Ian Rossman
Diagnosis and management of status epilepticus: improving the status quo.
The Lancet. Neurology · 2025 · 47 citations · Tobias Loddenkemper
Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis.
JAMA neurology · 2026 · 17 citations · Suma Babu
Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study.
The Lancet. Neurology · 2024 · 71 citations · Suma Babu
Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients.
Brain : a journal of neurology · 2026 · 13 citations · Tobias Loddenkemper
Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.
Brain : a journal of neurology · 2022 · 118 citations · Tobias Loddenkemper
Point-of-care ultrasound improves clinical outcomes in patients with acute onset dyspnea: a systematic review and meta-analysis.
Internal and emergency medicine · 2023 · 46 citations · Stefanie Madzsar